<div id="readability-page-1"><p>683 Capital Management LLC reduced its stake in shares of  Centene Corporation (NYSE:CNC - Free Report) by 35.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 170,000 shares of the company's stock after selling 95,000 shares during the quarter. 683 Capital Management LLC's holdings in Centene were worth $9,228,000 at the end of the most recent reporting period.</p><ul><li>MarketBeat Week in Review – 07/07 - 07/11</li></ul><p>Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Benjamin Edwards Inc. bought a new stake in  Centene during the 1st quarter valued at approximately $318,000.  Independent Advisor Alliance lifted its stake in shares of  Centene by 55.5% in the 1st quarter. Independent Advisor Alliance now owns 5,234 shares of the company's stock valued at $318,000 after purchasing an additional 1,868 shares during the period.  Public Sector Pension Investment Board boosted its position in shares of  Centene by 9.6% during the first quarter. Public Sector Pension Investment Board now owns 66,710 shares of the company's stock valued at $4,050,000 after purchasing an additional 5,825 shares in the last quarter.  HighTower Advisors LLC grew its stake in  Centene by 33.2% in the first quarter. HighTower Advisors LLC now owns 255,177 shares of the company's stock worth $15,492,000 after purchasing an additional 63,556 shares during the period.  Finally, Russell Investments Group Ltd. lifted its position in  Centene by 42.9% during the first quarter. Russell Investments Group Ltd. now owns 550,658 shares of the company's stock valued at $33,427,000 after buying an additional 165,288 shares during the period. Hedge funds and other institutional investors own  93.63% of the company's stock. </p><h2>Analyst Ratings Changes</h2><p>A number of analysts have recently weighed in on the stock. Jefferies Financial Group upped their target price on shares of Centene from $25.00 to $32.00 in a research report on Monday, November 3rd. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Centene from $24.00 to $32.00 in a report on Friday, October 31st. Cowen  reissued a &#34;hold&#34; rating on shares of Centene in a research report on Friday, October 31st. UBS Group  set a $42.00 price objective on Centene and gave the company a &#34;neutral&#34; rating in a research report on Thursday, October 30th. Finally, Oppenheimer  reissued an &#34;outperform&#34; rating and issued a $45.00 target price on shares of Centene in a report on Thursday, October 30th. Three analysts have rated the stock with a Buy rating, fourteen have issued  a Hold rating and three have issued  a Sell rating to the company. According to MarketBeat, Centene presently has a consensus rating of &#34;Hold&#34; and a consensus price target of $38.44.</p><ul><li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li></ul><p><b>Get Our Latest Stock Analysis on CNC</b></p><h2>Centene Stock Up 1.0%</h2><p>CNC stock opened at $40.85 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.08 and a quick ratio of 1.08. Centene Corporation has a 1-year low of $25.08 and a 1-year high of $66.81. The stock has a market capitalization of $20.08 billion, a P/E ratio of -3.78, a P/E/G ratio of 1.35 and a beta of 0.48. The business has a fifty day moving average price of $36.88 and a 200-day moving average price of $36.99. </p><ul><li>Top Analyst-Rated Healthcare Stocks to Watch Now</li></ul><p>Centene (NYSE:CNC - Get Free Report) last released its quarterly earnings data on Wednesday, October 29th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of ($0.21) by $0.71. The company had revenue of $49.69 billion during the quarter, compared to the consensus estimate of $47.50 billion. Centene had a positive return on equity of 7.82% and a negative net margin of 2.85%.Centene's revenue for the quarter was up 18.2% on a year-over-year basis. During the same period last year, the company earned $1.62 EPS.  Equities analysts forecast that  Centene Corporation will post 6.86 earnings per share for the current fiscal year. </p><h2>Centene Company Profile</h2> (Free Report)<p>Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Centene</li><li>10 Best Airline Stocks to Buy</li><li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li><li>High Flyers: 3 Natural Gas Stocks for March 2022</li><li>The Best Holiday Present You Can Give Yourself? Costco Stock</li><li>Stock Splits, Do They Really Impact Investors?</li><li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNOQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNOQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Centene Right Now?</h2><p>Before you consider Centene, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.</p><p>While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>683 Capital Management LLC reduced its stake in shares of Centene Corporation (NYSE:CNC - Free Report) by 35.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.</p>

683 Capital Management LLC Sells 95,000 Shares of Centene Corporation $CNC